Pfizer / BioNTech produces 100 million doses
After Johnson & Johnson allied itself with Aspen, it is Pfizer / BioNTech's turn to partner with a South African company to produce its anticovid vaccine. The manufacturer has signed an agreement with the Biovac Institute, a semi-state company based in Cape Town. This will be the first time a Messenger RNA vaccine has been produced in Africa. Target: 100 million doses per year by 2023. Production…